CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: The addition of 1 μM IM led to a mean 60% decrease in the clonogenicity of CML CD34+ cells, whereas 1 μM ALX decreased their clonogenic potential by approximately 70%, with a more homogeneous response compared to IM (Figure 5B).